Alligator Bioscience AB (LTS:0RK9)
kr 1.256 0 (0%) Market Cap: 934.77 Mil Enterprise Value: 869.05 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 33/100
Back to the Transcripts List

Q3 2020 Alligator Bioscience AB Earnings Call Transcript

Oct 22, 2020 / 12:00PM GMT
Release Date Price: kr1.76
Per NorlÃ;n
Alligator Bioscience AB - CEO

© -

Thank you so much. So welcome to this conference call, which will focus on today's interim report and the associated press release.

Slide 2. So as usual, the presentation does include some forward-looking statements.

Let's go to slide 3. We announced today that Alligator will focus clinical activities to our lead programs ATOR-1017 and mitazalimab. In short, the decision is based on the strong positioning and positive data for these two programs. One, there is a need for further evaluation of data in the ATOR-1015 program. So, our focus will be on ATOR-1017 and [mitam], while further clinical development for ATOR-1015 is to be conducted with a partner. These are the key messages, and I will now go into this in more detail.

First a slide summarizing the most recent news flow, Slide 4. So, during this third quarter, we had presented data from all three clinical programs as well as a novel bispecific drug concept, Neo-X-Prime and the recruitment of Gayle Mills as Chief Business Officer at Alligator.

Let's now

Already have an account? Log in
Get the full story
Start 7-Day Free Trial
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.